Regional differences in hepatitis C treatment with peginterferon and ribavirin in Japan: a retrospective cohort study

Kazuki Ide,1 Yohei Kawasaki,1 Hiroshi Yamada,1 Naohiko Masaki2 1Department of Drug Evaluation and Informatics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, 2The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Ide K (Dahkki), Kawasaki Y (Dahkki), Yamada H (Dahkki), Masaki N (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Dove Medical Press, 2016-03-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis